114636-23-6

Basic information

• Product Name: (E)-N-{[2-(2-chlorophenyl)hydrazinyl]methylidene}glycine
• CAS NO: 114636-23-6
• Molecular Formula: C₉H₁₀ClN₃O₂
• Molecular Weight: 227.6476
• Mol File: 114636-23-6.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 373.5°C at 760 mmHg
• Flash Point: 179.7°C
• Density: 1.36g/cm³
• Vapor Pressure: 3.06E-06mmHg at 25°C
• Refractive Index: 1.597
• CAS DataBase Reference: (E)-N-{[2-(2-chlorophenyl)hydrazinyl]methylidene}glycine(CAS DataBase Reference)
• NIST Chemistry Reference: (E)-N-{[2-(2-chlorophenyl)hydrazinyl]methylidene}glycine(114636-23-6)
• EPA Substance Registry System: (E)-N-{[2-(2-chlorophenyl)hydrazinyl]methylidene}glycine(114636-23-6)

Safety Data

• Hazardous Substances Data: 114636-23-6(Hazardous Substances Data)

Usage

General Description

(E)-N-{[2-(2-chlorophenyl)hydrazinyl]methylidene}glycine, also known as hydralazine, is a medication used to treat high blood pressure and heart failure. It works by relaxing the blood vessels, allowing the heart to pump more efficiently. This chemical is classified as a vasodilator, which means it widens the blood vessels, helping to reduce the workload on the heart and improve blood flow. Hydralazine can also be used in combination with other medications to treat certain types of heart disease. It is usually taken by mouth or given by injection and has shown to be effective in improving symptoms and reducing the risk of complications associated with high blood pressure and heart failure. However, it may cause side effects such as headaches, nausea, and dizziness, so it should be used under the guidance of a healthcare professional.